Improving understanding of biosimilars in the EU

September 13, 2018 – The European Medicines Agency (EMA) and the European CommissionExternal link icon have published additional information material on biosimilar medicines, as part of their ongoing collaboration to improve understanding of biosimilars across the European Union (EU). A biosimilar is biological medicine that is highly similar in all essential aspects to a ‘reference’ biological medicine already authorised. The new material includes an … (leggi tutto)